Get the latest insights on issues impacting mergers and acquisitions from RBC Capital Markets' investment banking team.
Perspectives from the cutting edge of biotech and pharma
Our serialized podcast series delivers highly differentiated insights and intelligence, turning today’s faster-moving trends into tomorrow’s opportunities
Fresh perspective and nuanced, data driven view of the forces shaping U.S. equity markets
Macro and market strategy series – explores the latest financial market and economic developments
Search all podcasts:
Markets in Motion
December 2023
Today in the podcast, our initial 2024 outlook. Our year-end 2024 S&P 500 price target is 5,000, for a 10% gain. Today...
Pathfinders in Biopharma
November 2023
In a market suppressed by inflation, how can the biotech industry continue to raise essential capital for innovation?...
Industries in Motion
The electric vehicle charging network in the U.S. has a long road to travel between now and 2030, according to RBC...
Three big things you need to know today: First, Growth sectors are typically the biggest beneficiaries of declining...
Strategic Alternatives Podcast
The equity capital market is technically open and some big IPOs have been delivered. Yet many investors and issuers...
October 2023
Today in the podcast, we take a deep dive into the stats and commentary for 3Q23 reporting season, as of late last week...
As RBC Capital Markets looks forward to a robust end to the year, John Hoffman and Jason Levitz, Co-Heads of Healthcare...
In this episode of the Industries in Motion podcast, Victoria McCulloch (Energy Services Analyst) discusses with Peter...
Today in the podcast, we take a deep dive into the outlook for the US equity market from the S&P 500 all the way down...
Get the latest insights from RBC Capital Markets delivered to your inbox.